st. Louis encephalitis

disease
On this page

Also known as Neuroinvasive St. Louis encephalitis virus infectionSaint Louis encephalitisSt. Louis encephalitis virus caused infectious encephalitisSt. Louis encephalitis virus infectious encephalitis

Summary

st. Louis encephalitis (MONDO:0005969) is a disease. A subtype of Flaviviridae infectious disease — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Prevalence: Unknown (Worldwide)

Clinical features

Epidemiology

Prevalence records

1 prevalence record(s), Orphanet:

TypeClassValueGeographyValidation
Annual incidence1-9 / 1 000 0000.38EuropeNot yet validated

Identifiers

Disease identifiers

FieldValue
Canonical namest. Louis encephalitis
Mondo IDMONDO:0005969
EFOEFO:0007495
MeSHD004674
Orphanet83484
DOIDDOID:10845
ICD-10-CMA83.3
ICD-111306878274
SNOMED CT417607009
UMLSC0014060
MedGen41773
GARD0019041
MedDRA10041896
Is cancer (heuristic)no

Also known as: Neuroinvasive St. Louis encephalitis virus infection · Saint Louis encephalitis · St. Louis encephalitis virus caused infectious encephalitis · St. Louis encephalitis virus infectious encephalitis

Disease family

Classification path: disease › human disease › disease by etiologic mechanism › disease of primarily extrinsic mechanism › infectious diseaseviral infectious disease › primary viral infectious disease › Flaviviridae infectious disease › st. Louis encephalitis

Related subtypes (9): Powassan encephalitis, Murray valley encephalitis, West Nile fever, dengue disease, pestivirus infectious disease, Kyasanur forest disease, Omsk hemorrhagic fever, Zika virus infectious disease, yellow fever

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.